METTL14 targeted TROAP mRNA through m6A modification to reduce stability, thus inhibiting cell proliferation and suppressing the proliferative capacity of ovarian cancer cells in vitro and in vivo [25]. The gene discussed is METTL14; the disease is ovarian carcinoma.